Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Metformin for the Treatment of Recurrent Respiratory Papillomatosis
Corina Din-Lovinescu
,
Andrew Blitzer
Research output
:
Contribution to journal
›
Article
›
peer-review
2
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Metformin for the Treatment of Recurrent Respiratory Papillomatosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Metformin
100%
Recurrent Respiratory Papillomatosis
100%
Low Risk
9%
Malignancy
9%
Type 2 Diabetes Mellitus (T2DM)
9%
Disease Progression
9%
Surgical Procedures
9%
Disease Burden
9%
Treatment Options
9%
Twice Daily
9%
Follow-up Time
9%
Non-diabetic
9%
Gastrointestinal Upset
9%
Adult-onset
9%
Mutagenesis
9%
Oral Agents
9%
Reduced Time
9%
Self-limiting
9%
Spontaneous Regression
9%
Lightheadedness
9%
Antiproliferative Properties
9%
Metabolic Requirements
9%
Facial Flushing
9%
Medicine and Dentistry
Glycon
100%
Papillomatosis
100%
Cancer
9%
Maturity Onset Diabetes of the Young
9%
Surgical Technique
9%
Diabetes Mellitus
9%
Spontaneous Remission
9%
Gastrointestinal Distress
9%
Dizziness
9%
Mutagenesis
9%
Diseases
9%
Oral
9%
Treatment Option
9%
Side Effect
9%